Title

Intravenous Lidocaine Versus Morphine for Severe Pain in the ED
Intravenous Lidocaine Versus Provider Chosen Dose of Morphine for the Treatment of Severe Pain in the Emergency Department: An Open-label Randomized Controlled Pilot Study
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Indication/Condition

    Pain
  • Intervention/Treatment

    lidocaine morphine ...
  • Study Participants

    32
Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider chosen dose of IV morphine for the treatment of severe pain in the emergency department.

Study design: Open-label, randomized controlled pilot study.
Objective: The purpose of this pilot study is to determine the analgesic efficacy of intravenous lidocaine versus morphine for the treatment of severe pain in the emergency department (ED).

Study design: Open-label, randomized, controlled pilot trial. Participants: Investigators and research assistants will recruit patients ≥18 years old with severe pain (NRS ≥7) and an anticipated stay in the emergency department ≥1 hour. A sample size calculation was performed and 32 patients will be enrolled.

Intervention: After a trained research assistant obtains written informed consent, eligible participants will be randomized to the intravenous lidocaine or morphine arms of the study. In the intravenous lidocaine arm, patients will receive IV lidocaine (75 mg if <50kg, 100 mg if 50 - 100 kg, and 150 mg if >100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if <50kg, 100 mg if 50 - 100 kg, and 150 mg if >100 kg). In the morphine arm, the ED provider will choose an appropriate dose of morphine for the patient. At 20 and 40 minutes, the participants will be asked "Would you like additional pain medication?". Participants responding in the affirmative will receive morphine 4 mg IV.

Data collection: The trained research assistant will collect data on the patients' pain scores, side effects, and rescue morphine.

Statistical analysis: Investigators will perform descriptive statistics and compare pain scores and pain relief at each time point with unpaired t-tests.
Study Started
Mar 31
2016
Primary Completion
Sep 30
2016
Study Completion
Sep 30
2016
Results Posted
Apr 06
2020
Last Update
Apr 06
2020

Drug Intravenous lidocaine

Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes

  • Other names: lignocaine, Xylocaine

Drug Intravenous morphine

Emergency department provider chooses appropriate dose of intravenous morphine

  • Other names: duramorph

Intravenous lidocaine Experimental

Participants will receive IV lidocaine (75 mg if <50kg, 100 mg if 50 - 100 kg, and 150 mg if >100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if <50kg, 100 mg if 50 - 100 kg, and 150 mg if >100 kg) in a 100 mL normal saline minibag. At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.

Morphine Active Comparator

ED provider will choose an appropriate dose of intravenous morphine for the patient. At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.

Criteria

Inclusion Criteria:

Subject has severe pain (NRS ≥7)
Subject has anticipated ED stay of ≥1 hour

Exclusion Criteria:

High acuity trauma patients
Patients deemed to critically ill by ED provider
Active psychosis
Pregnancy
History of heart block or bradycardia
Allergy to lidocaine or amide type local anesthetic
History of seizures

Summary

Intravenous Lidocaine

Morphine

All Events

Event Type Organ System Event Term Intravenous Lidocaine Morphine

Pain Score (NRS 0-10)

Pain score is rated on the Numeric Rating Scale from 0-10. 0 represents no pain and 10 represents the worst possible pain.

Intravenous Lidocaine

5.1
units on a scale (Mean)
95% Confidence Interval: 3.3 to 6.8

Morphine

4.2
units on a scale (Mean)
95% Confidence Interval: 3.0 to 5.4

Pain Score (NRS 0-10)

Pain score recorded on the numeric rating scale 0-10.

Intravenous Lidocaine

8.1
units on a scale (Mean)
95% Confidence Interval: 7.1 to 9.0

Morphine

8.9
units on a scale (Mean)
95% Confidence Interval: 8.3 to 9.6

Pain Score (NRS 0-10)

Pain score recorded on the numeric rating scale 0-10. 0 represents no pain and 10 represents the worst pain.

Intravenous Lidocaine

7.4
units on a scale (Mean)
95% Confidence Interval: 6.3 to 8.4

Morphine

6.2
units on a scale (Mean)
95% Confidence Interval: 4.6 to 7.8

Pain Score (NRS 0-10)

Pain score recorded on the numeric rating scale 0-10.

Intravenous Lidocaine

7.0
units on a scale (Mean)
95% Confidence Interval: 5.9 to 8.1

Morphine

5.6
units on a scale (Mean)
95% Confidence Interval: 4.0 to 7.1

Pain Score (NRS 0-10)

Pain score recorded on the numeric rating scale 0-10.

Intravenous Lidocaine

6.3
units on a scale (Mean)
95% Confidence Interval: 5.0 to 7.5

Morphine

4.7
units on a scale (Mean)
95% Confidence Interval: 3.2 to 6.3

Pain Score (NRS 0-10)

Pain score recorded on the numeric rating scale 0-10.

Intravenous Lidocaine

5.6
units on a scale (Mean)
95% Confidence Interval: 4.1 to 7.1

Morphine

4.6
units on a scale (Mean)
95% Confidence Interval: 3.1 to 6.0

Pain Relief at 10 Minutes Compared to Baseline.

Pain NRS at 0 minutes minus pain NRS at 10 minutes

Intravenous Lidocaine

1.1
units on a scale (Mean)
95% Confidence Interval: 0.5 to 1.8

Morphine

2.0
units on a scale (Mean)
95% Confidence Interval: 0.9 to 3.0

Pain Relief at 20 Minutes Compared to Baseline.

Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 20 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.

Intravenous Lidocaine

1.8
units on a scale (Mean)
95% Confidence Interval: 1.1 to 2.5

Morphine

2.8
units on a scale (Mean)
95% Confidence Interval: 1.4 to 4.1

Pain Relief at 30 Minutes Compared to Baseline.

Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 30 minutes NRS is a scale ranging from 0, no pain, to 10 worst pain.

Intravenous Lidocaine

2.2
units on a scale (Mean)
95% Confidence Interval: 1.4 to 3.0

Morphine

3.4
units on a scale (Mean)
95% Confidence Interval: 1.9 to 4.7

Pain Relief at 40 Minutes Compared to Baseline.

Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 40 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.

Intravenous Lidocaine

2.9
units on a scale (Mean)
95% Confidence Interval: 1.7 to 4.1

Morphine

4.2
units on a scale (Mean)
95% Confidence Interval: 2.9 to 5.6

Pain Relief at 50 Minutes Compared to Baseline.

Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 50 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.

Intravenous Lidocaine

3.6
units on a scale (Mean)
95% Confidence Interval: 2.2 to 5.0

Morphine

4.4
units on a scale (Mean)
95% Confidence Interval: 3.2 to 5.6

Pain Relief at 60 Minutes Compared to Baseline.

Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 60 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.

Intravenous Lidocaine

4.1
units on a scale (Mean)
95% Confidence Interval: 2.6 to 5.7

Morphine

4.8
units on a scale (Mean)
95% Confidence Interval: 3.7 to 5.8

Number of Participants Requiring Rescue Medications

The percentage of patients requiring rescue IV morphine at 20 and 40 minutes

Intravenous Lidocaine

Morphine

Patient Satisfaction

The proportion of patients saying, "Yes" to "Would you have this pain medication again for similar pain?"

Intravenous Lidocaine

Morphine

Number of Participants Reporting Adverse Events

Participants will be observed for the following adverse events and side effects: seizure, bradyarrhythmias, hyper or hypotension, perioral numbness, tinnitus, metallic taste, other, hypotension, hypoxia, nausea, vomiting, itching, or other side effects. Participants have the opportunity to report other side effects during the study

Intravenous Lidocaine

Morphine

Total

32
Participants

Age, Continuous

46
years (Median)
Inter-Quartile Range: 36.0 to 59.5

Race and Ethnicity Not Collected

0
Participants

Sex: Female, Male

Overall Study

Intravenous Lidocaine

Morphine